Health Care Reform and Innovation
This article was originally published in RPM Report
Executive Summary
The Secretary of Commerce spoke to the brand name pharmaceutical industry trade association days before enactment of health care reform. His theme: the Administration's commitment to biomedical innovation. There is a lot for industry to like in what he had to say.
You may also be interested in...
Biopharma's Default Position: Drug Stocks Hold Up Against US Downgrade
Economists are fretting that the US may be heading into a “lost decade” of stagnation. Will those fears help Big Pharma investors finally end a lost decade of their own?